These benefits, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two aid the thought of concentrating on ACKR3 as a novel strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. Disclaimer: The above can https://gailo727ajo2.bloggazza.com/profile